Susan Hasty, Publisher
Table of Contents . . . September 1st, 1997
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Gene Transfection Techniques - Electroporation Effectively Transfects Plasmids In Vitro and In Vivo
AIDS Vaccines - New Assay Screens Sera For Effective Anti-HIV Antibodies
Alzheimer's Disease - Gene Implicated In Lowering The Onset Age For Alzheimer's Disease
Autoimmune Disease - Immunization Protects Against Multiple Autoimmune Diseases
Breast Cancer - New Gene May Intensify Breast Cancer Growth
Cystic Fibrosis - IND Approval Received for Duramycin
DNA Vaccines - CTL Response and Protection against Tumor Challenge Elicited In Vivo
Genetic Testing - "A Question Of Genes: Inherited Risks" Airs September 16 On Public Television
Genetics - Key Gene For Telomerase Enzyme In Humans Discovered
Genetics - Mutation Appears To Delay AIDS Progression
Genetics - Proteome Project Collaboration Signed
HIV Gene Therapy - Vector Developed from MuLV Pseudotyped with HIV Envelope Glycoproteins
Immunology (HBV) - Vaccination Against Hepatitis B May Select Mutant Virus
Immunology (TB) - aroQ Mutants of C. pseudotuberculosis Could Have Vaccine Implications
Liver Disease - Efficiency of Retroviral-Mediated Gene Transfer Increased In Vivo
Melanoma - Antisense Targeting of bFGF and FGFR-1 Block Angiogenesis In Vivo
Therapy (TB) - embB Mutation Critical in Ethambutol Resistance
Cancer Gene Therapy - "Retrovirus Targeting to Melanoma Cells."
Cancer Gene Therapy - "Targeted Killing of Carcinoembryonic Antigen Producing Cancer Cells by Retrovirus Displaying a Single Chain Variable Fragment Antibody."
Cancer Gene Therapy - "Targeting of Human Breast Cancer Cells with MoMuLV Vectors Containing the EGF-Like Domain of Heregulin B1."
Cancer Gene Therapy - "Targeting the Tumor Vasculature Using Endothelial-Specific Promoters and Surface Markers."
Cancer Gene Therapy - "Towards Tetracyclin E-Regulated Retinoblastoma Gene Therapy."
Drug Development (HIV-1) - "Targeting to the HIV-1 RRE of the Influenza Virus NS-1 Protein Effector Domain as a Potent, Specific Anti-HIV Agent."
Genetics (HIV-1) - "The Product of Human Cytomegalovirus (HCMV) UL44 Downregulates HIV-1 LTR Transactivation Mediated by HIV Tat and HCMV-IE1/IE2."
Protease Gene Therapy - "Targeting of Retroviral Vectors Through Ligand-Receptor and Protease-Substrate Interactions."
Antisense Technology - "Antisense-Mediated Resistance to Measles Virus Infection in HeLa Cells."
Antisense Technology - "Antitumor Activity of a C-raf Antisense Oligonucleotide in Combination with Standard Chemotherapeutic Agents Against Various Human Tumors Transplanted Subcutaneously into Nude Mice."
Antisense Technology - "Enhanced Expression of bcl-2 Following Antisense Oligonucleotide Mediated Growth Factor Deprivation."
Cancer Gene Therapy - "Adeno-Associated Viral Vector Gene Transfer into Leptomeningeal Xenografts."
Cancer Gene Therapy - "Cancer Gene Therapy using a Novel Adeno-Associated Virus Vector Expressing Human Wild-Type p53."
Cystic Fibrosis - "HVJ (Sendai virus)-Cationic Liposomes: A Novel and Potentially Effective Liposome-Mediated Technique for Gene Transfer to the Airway Epithelium."
Cystic Fibrosis - "Incomplete Rescue of Cystic Fibrosis Transmembrane Conductance Regulator Deficient Mice by the Human CFTR cDNA."
DNA Vaccines - "Engineering of in vivo Immune Responses to DNA Immunization Via Codelivery of Costimulatory Molecule Genes."
Ophthalmology - "Gene Transfer to ex vivo Stored Corneas."
Ophthalmology - "Retrovirus-Mediated Transfer of the Suicide Gene into Retinal Pigment Epithelial Cells in vitro."
Vectors - "A Rapid Screening Procedure for the Identification of High-Titer Retrovirus Packaging Clones."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.